#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Liposarcoma recurrent Sarcoma Bulbospinal muscular atrophy congenital Malignant neoplasm of choroid Stress cardiomyopathy Acute on chronic liver failure Proteus syndrome Ependymoma Soft tissue sarcoma Pyruvate kinase deficiency anaemia Hyperoxaluria Synovial sarcoma ABO haemolytic disease of newborn Iron overload Thromboangiitis obliterans More trials…

    Learn about Rare Diseases

    Osteosarcoma metastatic – Life with Disease Cerebral arteriovenous malformation haemorrhagic – Trials in Disease Glycogen storage disease type V – Diagnostics Pulmonary sarcoidosis – Trials in Disease Phenylketonuria – Treatment Lennox-Gastaut syndrome – Trials in Disease Paroxysmal nocturnal haemoglobinuria – Trials in Disease Hepatic angiosarcoma – Basic Information Progressive supranuclear palsy – Diagnostics Hereditary hypophosphataemic rickets – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Azd4831 Nadunolimab AGA2118 Guanfacine Lenzumestrocel Piflufolastat (18F) Regn7075 ADS-019 Mercaptopurine Monohydrate MB-HUCART19.1 Treprostinil Palmitil Mocravimod Omp12 Cortisone Oms906 Captopril Benzocaine Treprostinil Ursodeoxycholic Acid Prasterone More therapies…

    Learn about Your Condition

    Toxic nodular goitre Craniopharyngioma Osteosarcoma metastatic Brain neoplasm Ewing's sarcoma metastatic Drug use disorder Hypersomnia Seasonal allergy Retroperitoneal cancer Gastrointestinal carcinoma Oesophagectomy Myocarditis Coma Procedural haemorrhage Frontotemporal dementia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • A study testing visugromab, nivolumab, and lenvatinib for patients with advanced liver cancer that cannot be removed by surgery after previous treatment failed

    Recruiting

    2 1 1
    Investigated Drugs:
    • VISUGROMAB
    • Sodium Chloride
    • Lenvatinib
    France Germany Italy Spain

  • A study to test if empasiprubart can improve function and is safe for adults with chronic inflammatory demyelinating polyneuropathy

    Recruiting

    3 1
    Investigated Drugs:
    • Empasiprubart
    Austria Bulgaria Czechia Denmark Estonia Finland +9

  • Study of How Enzalutamide and Apalutamide Affect Dexamethasone Processing in the Body in Patients with Prostate Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Dexamethasone Phosphate
    • Enzalutamide
    • Apalutamide
    Sweden

  • A Study Testing How Well Bimekizumab Works and How Safe It Is for Adults with Palmoplantar Pustulosis

    Recruiting

    3 1 1
    Investigated Drugs:
    • Bimekizumab
    Czechia Denmark France Germany Hungary Italy +2

  • Study of MK-3120 for patients with high-risk non-muscle invasive bladder cancer who have not received or have received BCG treatment

    Recruiting

    1 1 1
    Investigated Diseases:
    • Bladder transitional cell carcinoma
    Investigated Drugs:
    • SKB410
    Austria Belgium France Greece Italy The Netherlands +2

  • Study of flumazenil for preventing emergence delirium in children after ear, nose and throat surgery

    Recruiting

    3 1 1
    Investigated Diseases:
    • Anaesthetic complication neurological
    Investigated Drugs:
    • Sodium Chloride
    Germany
Previous Page
1 … 78 79 80 81 82 … 1,646
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!